A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
Titel:
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
Auteur:
Santoro, A. Gebbia, V. Pressiani, T. Testa, A. Personeni, N. Arrivas Bajardi, E. Foa, P. Buonadonna, A. Bencardino, K. Barone, C. Ferrari, D. Zaniboni, A. Tronconi, M.C. Cartenì, G. Milella, M. Comandone, A. Ferrari, S. Rimassa, L.